COL16A1 c.4291G>A ;(p.G1431R)

Variant ID: 1-32120459-C-T

NM_001856.3(COL16A1):c.4291G>A;(p.G1431R)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Angiosarcoma heterogeneity and potential therapeutic vulnerability to immune checkpoint blockade: insights from genomic sequencing.

Genome Medicine
Boichard, Amélie A; Wagner, Michael J MJ; Kurzrock, Razelle R
Publication Date: 2020-07-09

Variant appearance in text: COL16A1: 4291G>A; G1431R
PubMed Link: 32646514
Variant Present in the following documents:
  • 13073_2020_753_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



Modelling mutational landscapes of human cancers in vitro.

Scientific Reports
Olivier, Magali M; Weninger, Annette A; Ardin, Maude M; Huskova, Hana H; Castells, Xavier X; Vallée, Maxime P MP; McKay, James J; Nedelko, Tatiana T; Muehlbauer, Karl-Rudolf KR; Marusawa, Hiroyuki H; Alexander, John J; Hazelwood, Lee L; Byrnes, Graham G; Hollstein, Monica M; Zavadil, Jiri J
Publication Date: 2014-03-27

Variant appearance in text: COL16A1: G1431R
PubMed Link: 24670820
Variant Present in the following documents:
  • srep04482-s4.xls, sheet 18
View BVdb publication page